MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0006655
SP Accure Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹247.88 Cr
▲ 36% YoY
Net profit · FY 2024
₹15.98 Cr
Net margin 6.4%
EBITDA · FY 2024
₹44.32 Cr
EBITDA margin 17.9%
Authorised capital
₹18 Cr
Registered with MCA
Paid-up capital
₹17.64 Cr
Issued & subscribed
Open charges
₹212.07 Cr
Satisfied ₹26 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
236
Provident fund records
About SP Accure Labs Private Limited
Data last updated:
SP Accure Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC090271. Its GSTIN is 36AATCS6976P1ZY (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹18 Cr and a paid-up capital of ₹17.64 Cr. It is led by directors Manikya Swarna Latha Kodali and Vijayaprakash Katikala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 18 – 17/1/F – 2 City Home Residency Road No 3 Kamala Nagar, Hyderabad, Telangana, India – 500060.
As per the financials filed for FY 2024, the company reported a revenue of ₹247.88 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹15.98 Cr (net margin 6.4%) and EBITDA of ₹44.32 Cr (EBITDA margin 17.9%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 28% over five years.
The company has about 236 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SP Accure Labs. As per MCA filings, the company has open charges of ₹212.07 Cr and satisfied charges of ₹26 Cr on record. Court records list 15 cases involving the company, including 5 filed by the company and 10 filed against it; 3 cases are pending. The company has 16 deals on record (13 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹19.9 Cr; the latest was in March 2021.
SP Accure Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0006655). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spaccurelabs.com.
Company details
CIN U24232TG2013PTC090271
Registration Number 090271
Incorporation Date 30 September 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0006655
CIN history
SP Accure Labs has one previous CIN (Corporate Identification Number): U24232AP2013PTC090271. The current CIN is U24232TG2013PTC090271, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC090271 | Current |
| U24232AP2013PTC090271 | Previous |
Recognitions & Rankings of SP Accure Labs
Contact details
SP Accure Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is spaccurelabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address18 – 17/1/F – 2 City Home Residency Road No 3 Kamala Nagar, Hyderabad, Telangana, India – 500060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of SP Accure Labs Private Limited, buy the company report.
Comprehensive company report
SP Accure Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
SP Accure Labs operates one associated brand: SP Accure Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A specialty pharmaceutical company leading in research, manufacturing, and marketing of high-quality products. | spaccurelabs.com |
Business activity
The main business activity of SP Accure Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of SP Accure Labs Private Limited, buy the company report.
Financials of SP Accure Labs Private Limited
FY 2024 filings availableSP Accure Labs Private Limited reported revenue of ₹247.88 Cr (up 36% YoY) for FY 2024.
Revenue · FY 2024
₹247.88 Cr ▲ 36%
Net profit · FY 2024
₹15.98 Cr margin 6.4%
EBITDA · FY 2024
₹44.32 Cr margin 17.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 39%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 36%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 36% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.98 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.9% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SP Accure Labs Private Limited, buy the company report.
Board of directors of SP Accure Labs Private Limited
SP Accure Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manikya Swarna Latha Kodali Also directs: SPPT Chem Private Limited, Sanozen Pharma Private Limited | Director | 30 Sep 2013 | 13 Years 0 Months | Current |
| Vijayaprakash Katikala Also directs: SPPT Chem Private Limited, Sanozen Pharma Private Limited | Director | 30 Sep 2013 | 13 Years 0 Months | Current |
Auditor
SP Accure Labs Private Limited is audited by Vasg & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vasg & Associates | FY 2023 | 006070S |
Shareholding
The shareholding of SP Accure Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SP Accure Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹212.07 Cr
Satisfied charges
₹26 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2025 | 101119313 | Others | ₹1.5 Cr | Open | |
| 25 Feb 2025 | 101061291 | Others | ₹2.99 Cr | Open | |
| 20 Nov 2024 | 101015485 | Others | ₹1.11 Cr | Open | |
| 17 Sep 2024 | 100999637 | Others | ₹42 Cr | Open | |
| 21 Aug 2024 | 101018554 | Others | ₹15 Cr | Open |
To see the full charge records of SP Accure Labs Private Limited, buy the company report.
Total charge records: 22 View all charges
Deals & funding
SP Accure Labs Private Limited has 16 deals on record (13 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹19.9 Cr; the latest was in March 2021.
Total deals
16
Funding rounds
13
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹19.9 Cr
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Accure Labs Private Limited |
| Mar 2015 | Funding round | ₹90 Lakh | Investors: Accure Labs Private Limited |
| Jan 2015 | Funding round | ₹2.5 Cr | Investors: Accure Labs Private Limited |
| Nov 2014 | Funding round | ₹1.1 Cr | Investors: Accure Labs Private Limited |
| Sep 2014 | Funding round | ₹50 Lakh | Investors: Accure Labs Private Limited |
To see the full deal history of SP Accure Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
SP Accure Labs Private Limited has 15 court cases on record: 5 filed by SP Accure Labs, 10 filed against it. 3 cases are pending and 12 are disposed.
Total cases
15
Filed by the company
5
Filed against the company
10
Pending
3
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 6 | 3 |
| High courts | 4 | 3 | 0 |
| Supreme Court | 3 | 1 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mohali, Punjab | Civil suit | Filed against the company by M/S Adley Lab Limited | Pending |
| District court, South, Delhi | Commercial suit | Filed against the company by Three Aces Global Logistics Pvt Ltd | Disposed |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Hetero Labs Ltd., Rep. by Mr. Bala Maheswar Reddy | Disposed |
| Supreme Court | Court case (-Ordinary Civil Matters) | Filed against the company by M/S Accure Labs Pvt. Ltd. Authorised Representative Ms. Mukti Swarup Flat No. 1406A, 14Th Floor, Building No. 89, Hemkunth Chamber, Nehru Place ,New Delhi , Delhi | Disposed |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Three Aces Global Logistics Pvt Ltd | Disposed |
To see the full case history of SP Accure Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
SP Accure Labs Private Limited was last rated by Icra on 06 Jul 2015.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 06 Jul 2015 |
To see the full credit ratings and regulatory alerts of SP Accure Labs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SP Accure Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SP Accure Labs Private Limited has a workforce of 236 employees on its EPFO records as of Jun 27, 2024, across 1 active EPFO establishment.
Employee count
236
Active EPFO establishments
1
Employee growth
12.38%
GST
SP Accure Labs has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCS6976P1ZY | Telangana | Active | 01 Jul 2017 |
| 07AATCS6976P1ZZ | Delhi | Active | 21 Sep 2022 |
To see the full GST registrations and return filing status of SP Accure Labs Private Limited, buy the company report.
Recent activity
SP Accure Labs Private Limited has 6 board changes on record since 2013: 4 appointments and 2 cessations. The latest: Asit Chandra Bose ceased to be Additional Director on 03 Aug 2018.
Charges
A charge with Others of Rs. 42.00 Cr registered on 17 Sep 2024 with Charge ID 100999637 was modified on 06 Jan 2026.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101119313 was registered on 31 May 2025.
Charges
A charge with Others amounted to Rs. 2.99 Cr with Charge ID 101061291 was registered on 25 Feb 2025.
Charges
A charge with Others amounted to Rs. 1.11 Cr with Charge ID 101015485 was registered on 20 Nov 2024.
AGM
Sp Accure Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 42.00 Cr with Charge ID 100999637 was registered on 17 Sep 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101018554 was registered on 21 Aug 2024.
Filing
Sp Accure Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100840925 was registered on 31 Oct 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 75.00 Cr registered on 21 Dec 2020 with Charge ID 100401514 was modified on 20 May 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.16 Cr with Charge ID 100748132 was registered on 08 May 2023.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100737681 was registered on 28 Apr 2023.
26 earlier events are in the company report.
Frequently asked questions
SP Accure Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 September 2013 (13+ years old) and is registered under CIN U24232TG2013PTC090271.
SP Accure Labs has 2 current directors:
- Manikya Swarna Latha Kodali - Director
- Vijayaprakash Katikala - Director
The latest financial statements of SP Accure Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of SP Accure Labs is 36AATCS6976P1ZY, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 07AATCS6976P1ZZ (Delhi).
The CIN (Corporate Identification Number) of SP Accure Labs is U24232TG2013PTC090271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SP Accure Labs has 15 court cases on record: 5 filed by the company and 10 filed against it. 3 are pending. Most are in the district courts.
SP Accure Labs was incorporated on 30 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
SP Accure Labs has 16 deals on record (13 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹19.9 Cr; the latest was in March 2021.
Asit Chandra Bose ceased to be Additional Director on 03 Aug 2018. Asit Chandra Bose was appointed as Additional Director on 01 Aug 2016. Ratan Capoor ceased to be Director on 01 Aug 2016. SP Accure Labs has 6 board changes on record in total.
Yes, SP Accure Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0006655).